MedPath

Investigating the effect of astaxanthin supplementation on heart failure

Phase 3
Conditions
Heart failure.
Heart failure
Registration Number
IRCT20200429047235N3
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
80
Inclusion Criteria

Age 18 years and above
known heart failure in stage C, D based on American Heart Association(AHA) criteria and cardiologist diagnosis
Willingness to participate in the study and completion of the consent form

Exclusion Criteria

Pregnancy and breastfeeding
Consumption of alcoholic beverages
Drug addiction
Suffering from uncontrolled diabetes
Use of herbal and medicinal supplements especially antioxidant supplements three months before starting the study
Warfarin drug use
Following a special diet or exercise program
Suffering from chronic liver, kidney and lung diseases
Suffering from chronic inflammatory diseases such as Crohn's and ulcerative colitis
Suffering from cancer
Suffering from acute coronary heart syndrome or heart surgery in the last 4 weeks.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath